• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Solta tanks amid mixed quarter, CEO shuffle

Solta tanks amid mixed quarter, CEO shuffle

August 12, 2013 By Arezu Sarvestani

Solta tanks amid mixed quarter, CEO shuffle

Despite a relatively strong 2nd-quarter financial report, shares of Solta Medical (NSDQ:SLTM) took a dive last week, losing more than 16% of its share value in a matter of days.

The Hayward, Calif.-based device maker posted profits of $3.8 million, or 5¢ per diluted share, on sales of $43.2 million during the 3 months ended June 30. That compares with losses of $26.3 million, or 43¢ per share, on sales of $37.3 million during the same period last year.

Adjusted for 1-time expenses, the company reported earnings of 2¢ per share, blowing away the expectations of analysts, who had projected a 3¢-loss for the quarter. Nonetheless, news of the CEO change and uncertainty about the future scared Wall Street away in a flurry.

Stephen Fanning stepped down from his role as company president, CEO and board member, according to a press statement, to be replaced in the interim by current board chairman Mark Sieczkarek. A search for a new chief is underway.

The company also lowered its full-year guidance to $165 million in revenue, compared to its previous estimate of $180 million. Adjusted earnings are now expected to be approximately $10 million for the full year, compared to previous estimates at $13-16 million.

"While Q2/13 was mixed, a CEO change and lowered guidance for 2013 sets up for a tumultuous six months," analysts at Canaccord Genuity wrote, lowering their guidance from a "hold" to a "buy" rating. "Given uncertainty surrounding the new CEO’s strategy, we believe it wise to recommend investors wait until more clarity before adding to or taking new positions."

SLTM shares closed at $2.25 on Thursday, August 8, down 16.7% from the pre-earnings value of $2.70 on the morning of Monday, August 5. Shares had lost another few points by midday Friday, trading at $2.21 as of about 1:20 p.m.

Filed Under: MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: 2013, Personnel Moves, Q2, Solta Medical Inc.

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy